Basic Information
| RNALocate ID: | RLID:01002786 |
| RNA Symbol: | hsa-miR-1275 |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-1275 |
| RNA ID: | miRBase:MIMAT0005929 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 27396686 |
| Tissue/Cell Line: | HeLa cells |
| Method: | Microarray|qRT-PCR |
| Description: | Interestingly, miRNA loaded AGO2 and AGO3 proteins has been recently found in mitochondria [19] (Fig. 2), however, the main AGO binding partner-GW182- was absent [185], indicating that the common cytoplasmic RNA-silencing machinery does not operate in mitochondria. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002787 | Mitochondrion | HeLa cells | 27563705 |
| RLID:01002788 | Mitochondrion | Cell line (HeLa) | 21695135 |
| RLID:01002789 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002790 | Nucleolus | HeLa cells | 23940654 |
| RLID:01002837 | Cytosol | Cell line (HeLa) | 21695135 |
| RLID:01002838 | Mitochondrion | Cell line (HeLa) | 21695135 |
| RLID:11004346 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11004347 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11004348 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000791 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
| RLID-D:11001721 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1275 | Oral squamous cell carcinoma | MNDR-E-MI-08791 |
| MNDR | hsa-miR-1275 | Estrogen-receptor positive breast cancer | MNDR-E-MI-08792 |
| MNDR | hsa-miR-1275 | Estrogen-receptor negative breast cancer | MNDR-E-MI-08793 |
| MNDR | hsa-miR-1275 | Progesterone-receptor positive breast cancer | MNDR-E-MI-08794 |
| MNDR | hsa-miR-1275 | Progesterone-receptor negative breast cancer | MNDR-E-MI-08795 |
| MNDR | hsa-miR-1275 | Her2-receptor positive breast cancer | MNDR-E-MI-08796 |
| MNDR | hsa-miR-1275 | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-08797 |
| MNDR | hsa-mir-1275 | Colorectal carcinoma | MNDR-E-MI-08798 |
| MNDR | hsa-miR-1275 | B cell acute lymphoblastic leukemia | MNDR-E-MI-08799 |
| MNDR | hsa-miR-1275 | Prostate cancer | MNDR-E-MI-08800 |
| MNDR | hsa-miR-1275 | Alzheimer disease | MNDR-E-MI-08801 |
| MNDR | hsa-miR-1275 | Intracranial aneurysm | MNDR-E-MI-08802 |
| MNDR | hsa-miR-1275 | Polycystic ovary syndrome | MNDR-E-MI-08803 |
| MNDR | hsa-miR-1275 | Head and neck cancer | MNDR-E-MI-08804 |
| MNDR | hsa-miR-1275 | Lung cancer | MNDR-E-MI-08805 |
| MNDR | hsa-miR-1275 | Parkinson disease | MNDR-E-MI-08806 |
| MNDR | hsa-miR-1275 | Breast cancer | MNDR-E-MI-08807 |
| MNDR | hsa-mir-1275 | Squamous carcinoma | MNDR-E-MI-08808 |
| MNDR | hsa-miR-1275 | Pancreatic cancer | MNDR-E-MI-08809 |
| MNDR | hsa-miR-1275 | Nephroblastoma | MNDR-E-MI-08810 |
| MNDR | hsa-miR-1275 | Multiple sclerosis | MNDR-E-MI-08811 |
| MNDR | hsa-miR-1275 | Multiple sclerosis relapsing-remitting | MNDR-E-MI-08812 |
| MNDR | hsa-miR-1275 | Ovarian cancer | MNDR-E-MI-08813 |
| MNDR | hsa-miR-1275 | Glioma | MNDR-E-MI-08814 |
| MNDR | hsa-miR-1275 | Amyotrophic lateral sclerosis | MNDR-E-MI-08815 |
| MNDR | hsa-miR-1275 | Liver cancer | MNDR-E-MI-08816 |
| MNDR | hsa-mir-1275 | Non-small cell lung cancer | MNDR-E-MI-08817 |
| MNDR | hsa-miR-1275 | Lung adenocarcinoma | MNDR-E-MI-08818 |
| MNDR | hsa-miR-1275 | Thyroid carcinoma | MNDR-E-MI-08819 |
| MNDR | hsa-miR-1275 | Pancreatic adenocarcinoma | MNDR-E-MI-08820 |
| MNDR | hsa-miR-1275 | Intrahepatic cholangiocarcinoma | MNDR-E-MI-08821 |
| MNDR | hsa-miR-1275 | Cholangiocarcinoma | MNDR-E-MI-08822 |
| MNDR | hsa-miR-1275 | Adenoma | MNDR-E-MI-08823 |
| MNDR | hsa-miR-1275 | Progressive supranuclear palsy | MNDR-E-MI-08824 |
| MNDR | hsa-mir-1275 | Carcinoma hepatocellular | MNDR-E-MI-08825 |
| MNDR | hsa-miR-1275 | Hepatocellular carcinoma | MNDR-E-MI-08826 |
| MNDR | hsa-miR-1275 | Hodgkin lymphoma | MNDR-E-MI-08827 |
| MNDR | hsa-miR-1275 | Acute myelocytic leukemia | MNDR-E-MI-08828 |
| MNDR | hsa-mir-1275 | Colorectal cancer | MNDR-E-MI-08829 |
| MNDR | hsa-mir-1275 | Nasopharyngeal carcinoma | MNDR-E-MI-08830 |
| MNDR | hsa-miR-1275 | Nasopharynx carcinoma | MNDR-E-MI-08831 |
| MNDR | hsa-miR-1275 | Nasopharyngeal cancer | MNDR-E-MI-08832 |
| MNDR | hsa-miR-1275 | Pseudorabies | MNDR-E-MI-08833 |
| MNDR | hsa-miR-1275 | Subarachnoid hemorrhage traumatic | MNDR-E-MI-08834 |
| MNDR | hsa-miR-1275 | Stroke lacunar | MNDR-E-MI-08835 |
| MNDR | hsa-miR-1275 | Breast cancer her3+ negative | MNDR-E-MI-08836 |
| MNDR | hsa-mir-1275 | Multiple sclerosis susceptibility | MNDR-E-MI-08837 |
| MNDR | hsa-mir-1275 | Stroke susceptibility | MNDR-E-MI-08838 |
| MNDR | hsa-miR-1275 | Tubulovillous adenoma | MNDR-E-MI-08839 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AK3 | Homo sapiens | RR00064570 |
TOP